FDB (First Databank) Achieves ISO 13485:2016 Certification - Quality Management System for Medical Devices

First DatabankFDB (First Databank) announced that it has achieved ISO 13485:2016, the Quality Management System (QMS) for medical devices. This is a significant step for FDB, the UK's leading supplier of prescribing decision support solutions and it paves the way for the company's journey towards up-classification of its solutions.

FDB's solutions are integrated into healthcare systems across a wide range of settings and enable evidence-based prescribing by providing essential checks to support clinicians. ISO 13485:2016 is a widely recognised and globally defined QMS, specific to medical devices, which is audited independently on a regular basis. ISO is the International Organization for Standardization, which develops and publishes international standards.

FDB already operated a QMS significantly above ISO 9001 but was keen to enhance policies and procedures to better serve their customers, clinicians and patients. The Compliance team at FDB worked intensively over 18 months with SGS United Kingdom Ltd to achieve certification. The work involved further strengthening FDB's existing focus on quality by making sure enhanced quality controls existed at every stage of every process.

Sarah Dransfield, Information Governance Manager, FDB says: "As FDB's medical data and solutions are used in the care and treatment of patients, it is vital that we do everything to ensure that our systems, solutions and data are both as safe as possible, and compliant with all relevant laws and regulations."

Darren Nichols, Managing Director, FDB says: "We are so proud of the whole team at FDB who have worked so hard to achieve this certification. It's a significant step to go from ISO 9001 to ISO 13485:2016, which has brought about a hugely positive culture change. In a patient safety driven business, we believe adherence to this higher standard required for medical devices, is vital and means that the necessary policies and procedures are in place to enable FDB to deliver clinical decision support products of a consistently higher quality."

FDB achieved ISO 13485:2016 in January 2023 under certificate number: GB23/00000056 with SGS United Kingdom Ltd. If you would like to learn more about FDB's solutions, please click here.

About FDB

FDB (First Databank) creates and delivers the world's most powerful drug knowledge that ignites, inspires, and illuminates critical medication decisions. We collaborate with our partners to help improve patient safety, operational efficiency, and health outcomes. Our solutions drive healthcare information systems that serve the majority of hospitals, GP practices, pharmacies and many other areas of healthcare and are used by thousands of clinicians every day.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...